Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (200)	1/26/1999 11:26:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 805

Immune response, diabetes: It would be nice if we could get a bit more idea about the prospects for diabetes and ctii's encapsulization technolgogy with stem cells...I will copy a post I put over on the "99" thread here and also read the news item Miljenko posted earlier from this url-- Message 7251889 thereby "negate the need for immunosuppression" if they were grafted into the body Continued stem cell subthread--diabetes: I guess the Pittsburgh Post-Gazette went to Dr. Block because he was close by...he is the co-director of the Protein Technology Center at the University of Pittsburgh School of Medicine... ...Block also is trying to apply these techniques to pancreatic islet cells, insulin-producing cells that might be used to treat diabetes (snip) He said the Italian- Canadian study "is good science and it's good functional science." Unlike Block's experiments in petri dishes, the scientists accomplished what appears to be a transdifferentiation of the stem cells in a living animal. So I would imagine those biotechs focusing on stem cell research all have research on diabetes going... so also note this PR from last month... CytoTherapeutics Obtains Exclusive, Worldwide Licenses to Technology for Discovering Pancreatic Stem/Progenitor Cells Proprietary Technology May Speed Discovery Useful in Treatment of Diabetes biz.yahoo.com Diabetes had not been at the forefront in my mind--I'd been focusing my thoughts on CNS and especially Parkinson's. But this part of the puzzle is also very interesting...especially if a very small company like ctii, happens to win the race... Of course I'd be pleased if one of the big cap pharma or big cap biotech companies realized suddenly that this microcap stock has a lead over everybody else and simply made a deal with ctii, or made a bid outright for the company. Of course who can say if ctii or Geron or one of the big caps themselves has the lead. I suppose a couple of Ph D's with the help of a few patent attorneys could do the exercise...a shame that all most of us can do is throw darts, but that will have to do. --Mike